Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cora N Sternberg

Showing results (81-90 of 357) with videos related to

Pageof 36
Sort By:
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 3, 2004
Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumoursCora N Sternberg, Peter Reichardt, Michelle Holland
Expert Opinion on Drug Metabolism & Toxicology|November 22, 2011
Clinical and pharmacokinetic evaluation of satraplatinGury Doshi, Guru Sonpavde, Cora N Sternberg
The New England Journal of Medicine|October 4, 2018
Enzalutamide in Castration-Resistant Prostate CancerMaha Hussain, Fred Saad, Cora N Sternberg
NEJM AI|October 20, 2025
The use of artificial intelligence for cancer therapeutic decision-makingOlivier Elemento, Sean Khozin, Cora N Sternberg
Expert Opinion on Investigational Drugs|January 31, 2008
Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinomaGuru Sonpavde, Thomas E Hutson, Cora N Sternberg
Drugs of Today (Barcelona, Spain : 1998)|December 4, 2009
Pazopanib for the treatment of renal cell carcinoma and other malignanciesGuru Sonpavde, Thomas E Hutson, Cora N Sternberg
European Urology|September 15, 2009
Metastatic renal cell carcinoma: recent advances in the targeted therapy eraGiuseppe Di Lorenzo, Riccardo Autorino, Cora N Sternberg
BJU International|November 8, 2008
Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancerAvishay Sella, Cora N Sternberg, Iwona Skoneczna, et al.
Expert Opinion on Drug Safety|August 7, 2012
Safety and tolerability of pazopanib in the treatment of renal cell carcinomaAndrea Zivi, Linda Cerbone, Federica Recine, et al.
Current Treatment Options in Oncology|January 27, 2016
Chemotherapy for Muscle-Invasive Bladder CancerPatrizia Trenta, Fabio Calabrò, Linda Cerbone, et al.
Pageof 36

Showing results (81-90 of 357) with videos related to

Sort By:
Pageof 36
European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society|September 3, 2004
Development of and clinical experience with capecitabine (Xeloda) in the treatment of solid tumoursCora N Sternberg, Peter Reichardt, Michelle Holland
Expert Opinion on Drug Metabolism & Toxicology|November 22, 2011
Clinical and pharmacokinetic evaluation of satraplatinGury Doshi, Guru Sonpavde, Cora N Sternberg
The New England Journal of Medicine|October 4, 2018
Enzalutamide in Castration-Resistant Prostate CancerMaha Hussain, Fred Saad, Cora N Sternberg
NEJM AI|October 20, 2025
The use of artificial intelligence for cancer therapeutic decision-makingOlivier Elemento, Sean Khozin, Cora N Sternberg
Expert Opinion on Investigational Drugs|January 31, 2008
Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinomaGuru Sonpavde, Thomas E Hutson, Cora N Sternberg
Drugs of Today (Barcelona, Spain : 1998)|December 4, 2009
Pazopanib for the treatment of renal cell carcinoma and other malignanciesGuru Sonpavde, Thomas E Hutson, Cora N Sternberg
European Urology|September 15, 2009
Metastatic renal cell carcinoma: recent advances in the targeted therapy eraGiuseppe Di Lorenzo, Riccardo Autorino, Cora N Sternberg
BJU International|November 8, 2008
Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancerAvishay Sella, Cora N Sternberg, Iwona Skoneczna, et al.
Expert Opinion on Drug Safety|August 7, 2012
Safety and tolerability of pazopanib in the treatment of renal cell carcinomaAndrea Zivi, Linda Cerbone, Federica Recine, et al.
Current Treatment Options in Oncology|January 27, 2016
Chemotherapy for Muscle-Invasive Bladder CancerPatrizia Trenta, Fabio Calabrò, Linda Cerbone, et al.
Pageof 36